Charles River Laboratories International Inc (MIL:1CRL) Share Price

Company Profile

Business description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Contact
251 Ballardvale Street
WilmingtonMA01887
USA
T: +1 781 222-6000
E: [email protected]
https://www.criver.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
20,100

Recommended

Strong demand growth and improved profit margins lead to a strong result from the sleep apnea device firm.

Shane Ponraj, CFA | 05 August 2025

Morningstar’s Greg Warren says Berkshire may have little choice but to take a hard look at this huge potential acquisition.

Joseph Taylor | 05 August 2025

A key provision of the new award is that Musk must remain in a senior leadership position at Tesla.

Seth Goldstein, CFA | 04 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,028.80	106.80	1.20%
CAC 40	7,647.22	15.21	0.20%
DAX 40	23,947.34	189.65	0.80%
Dow JONES (US)	44,173.64	585.06	1.34%
FTSE 100	9,174.43	46.13	0.51%
HKSE	24,902.53	169.08	0.68%
NASDAQ	21,053.58	403.45	1.95%
Nikkei 225	40,549.54	258.84	0.64%
NZX 50 Index	12,877.04	193.00	1.52%
S&P 500	6,329.94	91.93	1.47%
S&P/ASX 200	8,770.40	106.70	1.23%
SSE Composite Index	3,617.60	34.29	0.96%